Michael E Ray
Affiliation: Saint Louis University School of Medicine
- Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapyJeffrey Vainshtein
Department of Radiation Oncology, University of Michigan Hospital, Ann Arbor, MI, USA
Radiat Oncol 7:82. 2012....
- Potential surrogate endpoints for prostate cancer survival: analysis of a phase III randomized trialMichael E Ray
Radiology Associates of Appleton, Appleton, WI 54911, USA
J Natl Cancer Inst 101:228-36. 2009..We evaluated distant metastasis and general clinical treatment failure as potential surrogates for prostate cancer-specific survival by use of data from the Radiation Therapy and Oncology Group 92-02 randomized trial...